Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 22 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 4 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2021, titled " Zydus announces first patient randomised in EVIDENCES-XTM Phase II(b) clinical trial of Saroglitazar Mg in NASH ".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases